{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2018-0008","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2018-0008","name":[{"text":"Zoster: Dose #1 of RZV administered 4 weeks after previous dose of ZVL\nEvaluation_Test_Type: Interval: At Absolute Minimum\nGeneral_Description: This test case describes when a patient is administered the first dose of RZV (Shingrix) at 4 weeks after a previous dose of ZVL (Zostavax), that the dose is considered valid. Per current guidance, RZV is recommended to be spaced 8 weeks after ZVL, but it does not need to be repeated if administered at any point prior to that 8 weeks up to and including the same day."}],"gender":"female","birthDate":"1970-06-01"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0008-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"121","display":"ZOSTAVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"ZOSTAVAX"}]},"patient":{"reference":"Patient/2018-0008"},"date":"2020-06-01T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0008-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0008"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2018-0008"},"recommendation":[{"date":"2020-06-29T00:00:00.000","forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"notComplete","display":"Not Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2020-08-24T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2020-08-24T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2021-02-25T00:00:00.000"}],"protocol":{"doseSequence":3,"description":"Evaluation_Test_Type: Interval: At Absolute Minimum\nForecast_Test_Type: EvaluationRecommended based on minimum interval \nGeneral_Description: This test case describes when a patient is administered the first dose of RZV (Shingrix) at 4 weeks after a previous dose of ZVL (Zostavax), that the dose is considered valid. Per current guidance, RZV is recommended to be spaced 8 weeks after ZVL, but it does not need to be repeated if administered at any point prior to that 8 weeks up to and including the same day.","series":"ZOSTER"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}